- Home
- KALA vs ANGH Comparison
KALA vs ANGH Comparison
Compare KALA & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- ANGH
- Stock Information
- Founded
- KALA 2009
- ANGH 2012
- Country
- KALA United States
- ANGH United Arab Emirates
- Employees
- KALA N/A
- ANGH N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- KALA Health Care
- ANGH Consumer Discretionary
- Exchange
- KALA Nasdaq
- ANGH Nasdaq
- Market Cap
- KALA 26.2M
- ANGH 32.1M
- IPO Year
- KALA 2017
- ANGH N/A
- Fundamental
- Price
- KALA $5.86
- ANGH $0.48
- Analyst Decision
- KALA Strong Buy
- ANGH
- Analyst Count
- KALA 3
- ANGH 0
- Target Price
- KALA $14.00
- ANGH N/A
- AVG Volume (30 Days)
- KALA 118.3K
- ANGH 11.5K
- Earning Date
- KALA 08-05-2025
- ANGH 07-22-2025
- Dividend Yield
- KALA N/A
- ANGH N/A
- EPS Growth
- KALA N/A
- ANGH N/A
- EPS
- KALA N/A
- ANGH N/A
- Revenue
- KALA N/A
- ANGH $78,093,405.00
- Revenue This Year
- KALA N/A
- ANGH N/A
- Revenue Next Year
- KALA N/A
- ANGH N/A
- P/E Ratio
- KALA N/A
- ANGH N/A
- Revenue Growth
- KALA N/A
- ANGH 88.72
- 52 Week Low
- KALA $2.92
- ANGH $0.42
- 52 Week High
- KALA $11.20
- ANGH $1.08
- Technical
- Relative Strength Index (RSI)
- KALA 60.68
- ANGH 45.12
- Support Level
- KALA $4.36
- ANGH $0.47
- Resistance Level
- KALA $7.00
- ANGH $0.52
- Average True Range (ATR)
- KALA 0.71
- ANGH 0.02
- MACD
- KALA 0.16
- ANGH 0.00
- Stochastic Oscillator
- KALA 63.97
- ANGH 42.86
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.